Steven L. Hoerter
2019 - Deciphera Pharmaceuticals
In 2019, Steven L. Hoerter earned a total compensation of $9M as President and Chief Executive Officer at Deciphera Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $478,500 |
|---|---|
| Option Awards | $6,776,000 |
| Salary | $449,886 |
| Stock Awards | $1,320,800 |
| Total | $9,025,186 |
Hoerter received $6.8M in option awards, accounting for 75% of the total pay in 2019.
Hoerter also received $478.5K in non-equity incentive plan, $449.9K in salary and $1.3M in stock awards.
Rankings
In 2019, Steven L. Hoerter's compensation ranked 897th out of 13,971 executives tracked by ExecPay. In other words, Hoerter earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 897 out of 13,971 | 94th |
Division Manufacturing | 311 out of 5,692 | 95th |
Major group Chemicals And Allied Products | 89 out of 2,189 | 96th |
Industry group Drugs | 72 out of 1,875 | 96th |
Industry Pharmaceutical Preparations | 58 out of 1,387 | 96th |
Source: SEC filing on April 24, 2020.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Deciphera Pharmaceuticals in 2019.